These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 1188838)

  • 1. In vivo production of soluble complexes containing fibrinogen-fibrin related antigen during ancrod therapy.
    McKillop C; Edgar W; Forbes CD; Prentice CR
    Thromb Res; 1975 Sep; 7(3):361-72. PubMed ID: 1188838
    [No Abstract]   [Full Text] [Related]  

  • 2. Possible pathway for formation of fibrin degradation products during ancrod therapy.
    McKillop C; Edgar W; Forbes CD; Prentice CR
    Nature; 1975 Jun; 255(5510):638-40. PubMed ID: 1134556
    [No Abstract]   [Full Text] [Related]  

  • 3. Soluble fibrin complex production and proteolysis during ancrod therapy.
    McKillop C; Edgar W; Prentice CR; Forbes CD
    Scott Med J; 1975 May; 20(3):139-40. PubMed ID: 127379
    [No Abstract]   [Full Text] [Related]  

  • 4. Treatment of thrombosis by sequential therapy with ancrod followed by streptokinase. Clinical pharmacology and rheology.
    Forbes CD; Barbenell J; Prentice CR
    Haemostasis; 1976; 5(6):348-54. PubMed ID: 1017726
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SDS polyacrylamide gel characterization of serum FDP produced in response to ancrod and streptokinase/plasminogen infusion in man.
    Lane DA; Robbins A; Rampling MW; Kakkar VV
    Br J Haematol; 1977 May; 36(1):137-48. PubMed ID: 871418
    [No Abstract]   [Full Text] [Related]  

  • 6. Comparative effects of heparin, urokinase, and ancrod on intraglomerular coagulation induced in progressive Masugi nephritis.
    Dohi K; Fujioka M; Nakamoto Y
    Acta Pathol Jpn; 1982 Nov; 32(6):1047-52. PubMed ID: 6760667
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Coagulation studies during therapeutic application of arvin.
    Vinazzer H
    Thromb Res; 1976 Feb; 8(2):243-8. PubMed ID: 943132
    [No Abstract]   [Full Text] [Related]  

  • 8. Defibrination with ancrod in glomerulonephritis: effects on clinical and histologic findings and on blood coagulation.
    Pollak VE; Glueck HI; Weiss MA; Lebron-Berges A; Miller MA
    Am J Nephrol; 1982; 2(4):195-207. PubMed ID: 6816068
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of ancrod and heparin as anticoagulants following endarterectomy in the dog.
    Daniel TM; Pizzo SV; Mckee PA
    Ann Surg; 1976 Aug; 184(2):223-8. PubMed ID: 952568
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multiple courses of ancrod (Arvin) therapy.
    Kounis NG; Evans WH
    Br Med J; 1977 Jan; 1(6056):290-1. PubMed ID: 837082
    [No Abstract]   [Full Text] [Related]  

  • 11. The effects of defibrination with ancrod in experimental allergic glomerular injury.
    Naish PF; Evans DJ; Peters DK
    Clin Exp Immunol; 1975 May; 20(2):303-9. PubMed ID: 1212811
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Defibrinogenating enzymes.
    Bell WR
    Drugs; 1997; 54 Suppl 3():18-30; discussion 30-1. PubMed ID: 9360849
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The fibrinolytic response to ancrod therapy: characterization of fibrinogen and fibrin degradation products.
    Prentice CR; Hampton KK; Grant PJ; Nelson SR; Nieuwenhuizen W; Gaffney PJ
    Br J Haematol; 1993 Feb; 83(2):276-81. PubMed ID: 8457476
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Comparative effects of ancrod, urokinase and heparin on intraglomerular coagulation induced by progressive Masugi nephritis (author's transl)].
    Fujioka M
    Nihon Jinzo Gakkai Shi; 1980 Aug; 22(8):1113-24. PubMed ID: 7012408
    [No Abstract]   [Full Text] [Related]  

  • 15. Ancrod: understanding the agent.
    Illig KA; Ouriel K
    Semin Vasc Surg; 1996 Dec; 9(4):303-14. PubMed ID: 8958607
    [No Abstract]   [Full Text] [Related]  

  • 16. Controlled trial of the sequential use of streptokinase and ancrod in the treatment of deep vein thrombosis of lower limb.
    Tibbutt DA; Chesterman CN; Williams EW; Faulkner T; Sharp AA
    Thromb Haemost; 1977 Apr; 37(2):222-32. PubMed ID: 577626
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Defibrination with ancrod in nephrotoxic nephritis in rabbits.
    Thomson NM; Moran J; Simpson IJ; Peters DK
    Kidney Int; 1976 Nov; 10(5):343-7. PubMed ID: 794557
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A quantitative evaluation of anticoagulants in experimental nephrotoxic nephritis.
    Thomson NM; Simpson IJ; Peters DK
    Clin Exp Immunol; 1975 Feb; 19(2):301-8. PubMed ID: 1212801
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Aspects of defibrinogenation therapy].
    Klüken N
    Phlebologie; 1975; 28(1):39-41. PubMed ID: 1202532
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fibrinolysis in glomerulonephritis treated with ancrod: renal functional, immunologic and histopathologic effects.
    Kim S; Wadhwa NK; Kant KS; Pollak VE; Glas-Greenwalt P; Weiss MA; Hong CG
    Q J Med; 1988 Nov; 69(259):879-905. PubMed ID: 3078212
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.